LinkedIn Icon
September 2018
Boston

News & More

Here you will find the most up to date news
and press releases in the bispecific antibody space.

Bispec Press Oxis Biotech Scientific Advisory Board Member to Address World Summit on Cancer Research

View here

Amgen reports positive results from phase 2 study of Blincyto in patients with relapsed/refractory PH+ B-cell precursor ALL

Amgen reports positive results from phase 2 study of Blincyto in patients with relapsed/refractory PH+ B-cell precursor ALL

 View here

Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/ Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

 View here

2015 ASCO bispecific highlights

Table Summarizing the Bispecific Abstract Details from the 2015 ASCO Meeting

 View here

merrimack pr 08.05

Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer

 View here